
Despite some progress, the industry is still in a wait-and-see mode regarding the administration, Congress, and FDA.
Gil Roth is president of the Pharma & Biopharma OutsourcingAssociation, gil.roth@pharma-bio.org.
Published: February 1st 2017 | Updated:
Published: August 1st 2017 | Updated: